Cancer research and prevention
Understanding cancer through evidence
Clear, sourced reporting on tumor biology, targeted therapies, immunotherapies, and screening. Each article separates what a study found from what it might mean for care, and states the limits of the evidence.
Biological context
How tumors are classified and studied
Cancers are grouped by the tissue they arise from, their molecular profile, and their behavior under treatment. Genetic sequencing identifies biomarkers that help researchers understand which tumors respond to which mechanisms, and how that response is measured in trials.
Evaluating a treatment means following patients over time against a comparison group. Our reports explain trial phases, endpoints, and the statistical uncertainty that remains, so readers can judge how far a finding reaches.
Prevention and screening
What the evidence says about screening
Public health programs weigh the benefit of early detection against the risk of false positives and overdiagnosis. Screening recommendations rest on population data, and their value differs by cancer type, age group, and individual risk profile.
Genetic risk profiles can refine who is offered additional checks, but they do not predict individual outcomes. Our articles report prevention data with its sources and avoid presenting any single measure as a guarantee of protection.